Atp2a2tm1.1Iemr/Atp2a2+ Myl2tm1(cre)Krc/Myl2+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6Crl * C57BL/6J
|
normal
cardiovascular system phenotype |
J:155628
|
Atp2a2tm1.1Iemr/Atp2a2tm1.1Iemr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129P2/OlaHsd * C57BL/6J * FVB/N
|
abnormal cardiovascular system physiology |
J:157143
|
abnormal heart left atrium morphology |
J:157143
|
abnormal heart left ventricle pressure |
J:157143
|
abnormal myocardial fiber physiology |
J:157143
|
normal
cardiovascular system phenotype |
J:157143
|
decreased cardiac muscle contractility |
J:157143
|
decreased cardiac output |
J:157143
|
decreased heart rate |
J:157143
|
decreased systemic arterial systolic blood pressure |
J:157143
|
dilated heart atrium |
J:157143
|
enlarged heart |
J:157143
|
increased circulating noradrenaline level |
J:157143
|
Atp2a2tm1.1Iemr/Atp2a2tm1.1Iemr Tg(Myhca-cre)1Lrsn/0
involves: 129P2/OlaHsd * C57BL/6Crl * FVB
|
embryonic lethality during organogenesis, complete penetrance |
J:155628
|
Atp2a2tm1.1Raco/Atp2a2+
C57BL/6J-Atp2a2tm1.1Raco/Raco
|
abnormal blood circulation |
J:216004
|
abnormal calcium ion homeostasis |
J:216004
|
abnormal physiological neovascularization |
J:216004
|
abnormal vascular endothelial cell migration |
J:216004
|
abnormal vascular endothelial cell physiology |
J:216004
|
decreased angiogenesis |
J:216004
|
Atp2a2tm1.1Raco/Atp2a2tm1.1Raco
C57BL/6J-Atp2a2tm1.1Raco/Raco
|
abnormal vascular development |
J:216004
|
decreased embryo size |
J:216004
|
embryonic lethality between somite formation and embryo turning, complete penetrance |
J:216004
|
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H
|
decreased circulating alkaline phosphatase level |
J:211773
|
decreased mean platelet volume |
J:211773
|
increased fasting circulating glucose level |
J:211773
|
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2tm1b(EUCOMM)Hmgu
C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H
|
preweaning lethality, complete penetrance |
J:211773
|
Atp2a2tm1Fwuy/Atp2a2tm1Fwuy
involves: 129S1/Sv * 129X1/SvJ * Swiss
|
abnormal calcium ion homeostasis |
J:111247
|
abnormal cardiac muscle relaxation |
J:111247
|
abnormal locomotor activation |
J:111247
|
aorta coarctation |
J:111247
|
ascending aorta hypoplasia |
J:111247
|
atrial septal defect |
J:111247
|
bradykinesia |
J:111247
|
cardiac fibrosis |
J:111247
|
cardiac hypertrophy |
J:111247
|
cardiac interstitial fibrosis |
J:111247
|
decreased body weight |
J:111247
|
decreased cardiac muscle contractility |
J:111247
|
decreased litter size |
J:111247
|
dilated heart right ventricle |
J:111247
|
fatigue |
J:111247
|
globular heart |
J:111247
|
heart left ventricle hypertrophy |
J:111247
|
impaired righting response |
J:111247
|
increased heart left ventricle posterior wall thickness |
J:111247
|
increased heart left ventricle septal wall thickness |
J:111247
|
increased heart weight |
J:111247
|
neonatal lethality, incomplete penetrance |
J:111247
|
prenatal lethality, incomplete penetrance |
J:111247
|
thin ventricle myocardium compact layer |
J:111247
|
ventricular septal defect |
J:111247
|
Atp2a2tm1Ges/Atp2a2+
involves: 129X1/SvJ
|
abnormal osteoclast differentiation |
J:198051
|
Atp2a2tm1Ges/Atp2a2+
involves: 129X1/SvJ * Black Swiss
|
abnormal calcium ion homeostasis |
J:52186,
J:66006
|
abnormal cardiac muscle relaxation |
J:52186,
J:95608
|
cachexia |
J:69754
|
cardiac fibrosis |
J:69754,
J:95608
|
cardiac hypertrophy |
J:95608
|
congestive heart failure |
J:95608
|
decreased left ventricle systolic pressure |
J:52186
|
decreased systemic arterial blood pressure |
J:52186
|
decreased ventricle muscle contractility |
J:52186,
J:66006,
J:95608
|
dilated heart left ventricle |
J:95608
|
esophageal epithelium hyperplasia |
J:69754
|
heart left ventricle hypertrophy |
J:95608
|
hyperkeratosis |
J:69754
|
increased esophageal papilloma incidence |
J:69754
|
increased heart left ventricle posterior wall thickness |
J:95608
|
increased left ventricle diastolic pressure |
J:95608
|
increased response of heart to induced stress |
J:95608
|
increased skin papilloma incidence |
J:69754
|
increased squamous cell carcinoma incidence |
J:69754
|
increased susceptibility to induced morbidity/mortality |
J:95608
|
increased tongue papilloma incidence |
J:69754
|
increased tumor incidence |
J:69754
|
lethargy |
J:69754
|
penis prolapse |
J:69754
|
premature death |
J:69754
|
pulmonary edema |
J:95608
|
stomach epithelial hyperplasia |
J:69754
|
toenail hyperkeratosis |
J:69754
|
Atp2a2tm1Ges/Atp2a2tm1Ges
involves: 129X1/SvJ * Black Swiss
|
prenatal lethality, complete penetrance |
J:52186
|